As individuals age, their immune systems typically become less effective, leading to a decline in T cell populations and slower immune responses. This deterioration increases susceptibility to infections among older adults. To counteract this age-related decline, researchers from MIT and the Broad Institute have developed a method to temporarily reprogram liver cells, enhancing T cell function.
The study utilizes mRNA technology to deliver three key factors that promote T cell survival, aiming to compensate for the diminished output from the thymus—a critical organ in T cell maturation that begins to shrink in early adulthood. The research demonstrated that older mice treated with this mRNA approach exhibited larger and more diverse T cell populations and improved responses to vaccinations and cancer immunotherapy.
Feng Zhang, a senior author of the study, emphasizes the potential of this strategy to help older individuals maintain better health as they age. The research indicates that by restoring essential immune functions, it might be possible to prolong disease-free periods in older populations.
The team’s innovative approach involves creating a temporary "factory" in the liver, which can produce T cell-stimulating signals typically generated by the thymus. This method allows for effective delivery of mRNA to the liver, facilitating the production of three specific immune cues: DLL1, FLT-3, and IL-7. Following treatment, older mice showed significant improvements in T cell populations and responses to vaccines and immunotherapy drugs, suggesting that this strategy could be viable for future clinical applications.
The researchers plan to further investigate this approach in additional animal models and explore other factors that may enhance immune function. The study's findings contribute to ongoing efforts to understand and mitigate age-related immune decline.